Zimmer Biomet Holdings, Inc. (ZBH) Financials
Key financial figures for Zimmer Biomet Holdings, Inc. (Q2 2026).
Zimmer Biomet posted Q2 2026 net sales of $2.177 billion, up 4.8% reported and 4.0% organic constant currency, and raised full-year 2026 adjusted EPS guidance to $8.47-$8.59. Net sales of $2.177 billion, up 4.8% reported (+4.7% constant currency, +4.0% organic constant currency) year-over-year GAAP diluted EPS of $1.03, up 33.8% year-over-year; adjusted diluted EPS of $2.07, roughly flat versus $2.07 a year ago Adjusted operating margin of 25.7%, down from 27.8% a year ago on higher restructuring, litigation and other charges S.E.T. On the outlook: FY2026 reported net sales growth of 3.9% to 4.9%, constant currency growth of 3.4% to 4.4%, organic constant currency growth of 2.25% to 3.25%, and adjusted diluted EPS of $8.47 to $8.59 (raised from prior guidance of $8.40 to $8.55). Figures are for Q2 2026, as Zimmer Biomet Holdings, Inc. reported them.
- Revenue
- $2.2B
- Net Income
- $200M
- EPS
- $1.03
- Total Assets
- $22.8B
- Operating Cash Flow
- $448M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $2.2B | $198M | $1.03 | 14.98% | $331M |
| Q1 FY2026 | $2.1B | $238M | $1.22 | 17.88% | $284M |
| Q4 FY2025 | $2.2B | $140M | $0.70 | 12.83% | |
| Q3 FY2025 | $2.0B | $231M | $1.16 | 17.55% | |
| Q2 FY2025 | $2.1B | $153M | $0.77 | 14.44% | $298M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $8.2B | $705M | $3.55 | 16.55% | $1.5B |
| FY2024 | $7.7B | $904M | $4.43 | 16.74% | $1.1B |
| FY2023 | $7.4B | $1.0B | $4.88 | 17.28% | $1.2B |
Frequently asked questions
What was Zimmer Biomet Holdings, Inc.'s revenue last quarter?
Zimmer Biomet Holdings, Inc. reported revenue of $2.18 billion for Q2 FY2026, up 4.8% from the same period a year earlier.
Is Zimmer Biomet Holdings, Inc. profitable?
Yes. Zimmer Biomet Holdings, Inc. reported net income of $198.3 million for Q2 FY2026, a net margin of 9.11% on revenue.
How has Zimmer Biomet Holdings, Inc.'s margin trended?
Operating margin was 14.98% in Q2 FY2026, compared with 14.44% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Zimmer Biomet Holdings, Inc. generate?
Zimmer Biomet Holdings, Inc. generated free cash flow of $331.4 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Zimmer Biomet Holdings, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.